High Diagnostic Value of Anticalpastatin Autoantibodies in Rheumatoid Arthritis Detected by ELISA Using Human Erythrocyte Calpastatin as Antigen

Journal of Rheumatology

Volumn 31, Issue 1, 2004, Pages 17-22

  Iwaki Egawa, Sachiko ^a   Matsuno, Hiroaki ^f   Yudoh, Kazuo ^g   Nakazawa, Fujio ^b   Miyazaki, Kyousuke ^c   Ochiai, Akira ^c   Hirohata, Shunsei ^d   Shimizu, Masatoshi ^e   Watanabe, Yasuhiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c SEIKAGAKU CORPORATION   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Hino Hospital   (Japan)

^f TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^g ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticalpastatin autoantibodies; Calpastatin; ELISA; Erythrocyte; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; C REACTIVE PROTEIN; CALPASTATIN; CALPASTATIN AUTOANTIBODY; GELATINASE B; IMMUNOGLOBULIN G ANTIBODY; RHEUMATOID FACTOR; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; MIXED CONNECTIVE TISSUE DISEASE; OSTEOARTHRITIS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; OSTEOARTHRITIS; SENSITIVITY AND SPECIFICITY;

EID: 0347319153     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Harris ED Jr. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
3. Huet G, Flipo RM, Richet C, et al. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis. Clin Chem 1992;38:1694-7.
4. Lenarcic B, Gabrijelcic D, Rozman B, Drobnic-Kosorok M, Turk V. Human cathepsin B and cysteine proteinase inhibitors (CIPs) in inflammatory and metabolic joint diseases. Biol Chem Hoppe-Seyler 1988;369 Suppl:257-61.
5. Huet G, Flipo RM, Colin C, et al. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor a and interleukin-1. Arthritis Rheum 1993;36:772-80.
6. Fukui I, Tanaka K, Murachi T. Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint. Biochem Biophys Res Commun 1989;162:559-66.
7. Suzuki K, Shimizu K, Hamamoto T, Nakagawa Y, Hamakubo T, Yamamuro T. Biochemical demonstration of calpains and calpastatin in osteoarthritic synovial fluid. Arthritis Rheum 1990;33:728-32.
8. Yamamoto S, Shimizu K, Shimizu K, Suzuki K, Nakagawa Y, Yamamuro T. Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints. Arthritis Rheum 1992;35:1309-17.
9. Suzuki K, Shimizu K, Hamamoto T, Nakagawa Y, Murachi T, Yamamuro T. Characterization of proteoglycan degradation by calpain. Biochem J 1992;285:857-62.
10. Mimori T, Suganuma K, Tanami Y, et al. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc Natl Acad Sci USA 1995;92:7267-71.
11. Despres N, Talbot G, Plouffe B, Boire G, Ménard H-A. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J Clin Invest 1995;95:1891-6.
12. Menard H-A, El-Amine M. The calpain-calpastatin system in rheumatoid arthritis. Immunol Today 1996;17:545-7.
13. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum 1986;29:1039-49.
15. Iwaki-Egawa S, Watanabe Y, Matsuno H. Correlations between matrix metalloproteinase-9 and adenosine deaminase isozymes in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 2001;28:485-9.
16. Schlosser U, Lackner KJ, Scheckenhofer C, Schmitz G. Calpastatin autoantibodies: detection, epitope mapping, and development of a specific peptide ELISA. Clin Chem 1996;42:1250-6.
17. Lackner KJ, Schlosser U, Lang B, Schmitz G. Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and an analysis of patient sera. Br J Rheumatol 1998;37:1164-71.
18. Goldbach-Mansky R, Lee J, McCoy A, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-43.
19. Despres N, Boire G, Lopez-Longo FJ, Menard HA. The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 1994;21:1027-33.
20. Vincent C, De Keyser F, Masson-Bessiere C, Sebbag M, Veys EM, Serre G. Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides. Ann Rheum Dis 1999;58:42-8.
21. Schlosser U, Lackner KJ, Scheckenhofer C, et al. Autoantibodies against the protease inhibitor calpastatin: A new risk factor for venous thrombosis? Thromb Haemost 1997;77:11-3.
22. Wang LF, Wei SG, Miao SY, Liu QY, Koide SS. Calpastatin gene in human testis. Biochem Mol Biol Int 1994;33:245-51.
23. Koide SS, Wang L, Kamada M. Antisperm antibodies associated with infertility: properties and encoding genes of target antigens. Proc Soc Exp Biol Med 2000;224:123-32.
24. Kanazawa Y, Kaneshiro Y, Sawa M, et al. Domain reactivity of autoantibodies to calpastatin in patients with systemic rheumatic diseases. Mod Rheumatol 2000;10:38-44.
25. Vittecoq O, Salle V, Jouen-Beades F, et al. Autoantibodies to the 27 C-terminal amino acids of calpastatin are detected in a restricted set of connective tissue diseases and may be useful for diagnosis of rheumatoid arthritis in community cases of very early arthritis. Rheumatology Oxford 2001;40:1126-34.
26. Asada K, Shimada M, Shimojo T, et al. cDNA cloning of human calpastatin: sequence homology among human, pig, and rabbit calpastatins. J Enzyme Inhib 1989;3:49-56.
27. Emori Y, Kawasaki H, Imajoh S, Minami Y, Suzuki K. All four repeating domains of the endogenous inhibitor for calcium-dependent protease independently retain inhibitory activity. Expression of the cDNA fragments in Escherichia coli. J Biol Chem 1988;263:2364-70.
28. Takano E, Murachi T. Purification and some properties of human erythrocyte calpastatin. J Biochem (Tokyo) 1982;92:2021-8.
29. Otto H-H, Schirmeister T. Cysteine proteases and their inhibitors. Chem Rev 1997;97:133-71.
30. Yamanaka H, Matsuda Y, Tanaka M, et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 2000;43:852-8.